Hot Stocks | Sun Pharma, Tata Motors, NTPC may deliver up to 10% in short term
Traders and investors should adopt a buy approach, using the mentioned support level as a stop loss and waiting for higher levels to be achieved.30-06-2023
30-06-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201529-06-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Closure of Trading Window
Intimation regarding closure of trading window28-06-2023
Sun Pharma arm gets Health Canada approval for acne drug
This marks the second approval for a dermatology drug this month for Sun Pharma's Canada based subsidiary. Since this segment in the pharmaceutical market is witnessing strong traction, the approval will strengthen Sun Pharma's dermatology portfolio.27-06-2023
Sun Pharma arm gets Health Canada approval for acne drug
This marks the second approval for a dermatology drug this month for Sun Pharma's Canada based subsidiary. Since this segment in the pharmaceutical market is witnessing strong traction, the approval will strengthen Sun Pharma's dermatology portfolio.27-06-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith our Press Release relating to 'Sun Pharma Presents Data from First-in-Human Phase 1 Studies of GL0034 at the American Diabetes Association 83rd Scientific Sessions', which we shall be releasing after sending this letter to you.24-06-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 23, 2023 for Raksha Sudhir Valia23-06-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 19, 2023 for Raksha Sudhir Valia20-06-2023
Sun Pharma shares gain on Health Canada nod to acne control cream
The share touched a 52-week high of Rs 1,071.90 and a 52-week low of Rs 794.25 on 30 January, 2023 and 20 June, 2022, respectively.20-06-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith our Press Release relating to 'Sun Pharma Announces Health Canada Approval of PRWINLEVI(r) (clascoterone cream 1%) for Topical Treatment of Acne', which we shall be releasing after sending this letter to you. This submission is being made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.19-06-2023